Search research articles
Contact Us
Filters
Showing results (121-130 of 145) with videos related to
Page
of 15
Sort By:
Bone Marrow Transplantation
|
May 29, 2026
Comparative outcomes of umbilical cord blood transplantation versus haploidentical transplantation according to post-transplant cyclophosphamide use in adolescent and young adult patients
Ryu Yanagisawa, Itaru Kato, Hiromi Hayashi, et al.
Blood Neoplasia
|
June 23, 2025
Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myeloma
Tomoyasu Jo, Kyoko Yoshihara, Masaki Ri, et al.
International Journal of Hematology
|
May 17, 2021
Expression of activated integrin β7 in multiple myeloma patients
Naoki Hosen, Satoshi Yoshihara, Hiroyuki Takamatsu, et al.
American Journal of Hematology
|
November 20, 2024
Different impacts of granulocyte colony-stimulating factor administration on allogeneic hematopoietic cell transplant outcomes for adult acute myeloid leukemia according to graft type
Takaaki Konuma, Kazuaki Kameda, Kaoru Morita, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 2004
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
Yoshihiro Oka, Akihiro Tsuboi, Tetsuya Taguchi, et al.
Cancer Immunology, Immunotherapy : CII
|
May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients
Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, et al.
European Journal of Haematology
|
January 21, 2021
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis
Teruhito Takakuwa, Ryosuke Yamamura, Kensuke Ohta, et al.
Therapeutic Advances in Hematology
|
July 5, 2022
Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis
Yoshiyuki Onda, Junya Kanda, Hitomi Kaneko, et al.
Annals of Hematology
|
March 16, 2024
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study
Naokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa, et al.
British Journal of Haematology
|
April 25, 2023
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan
Tomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 145) with videos related to
Sort By:
Page
of 15
Bone Marrow Transplantation
|
May 29, 2026
Comparative outcomes of umbilical cord blood transplantation versus haploidentical transplantation according to post-transplant cyclophosphamide use in adolescent and young adult patients
Ryu Yanagisawa, Itaru Kato, Hiromi Hayashi, et al.
Blood Neoplasia
|
June 23, 2025
Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myeloma
Tomoyasu Jo, Kyoko Yoshihara, Masaki Ri, et al.
International Journal of Hematology
|
May 17, 2021
Expression of activated integrin β7 in multiple myeloma patients
Naoki Hosen, Satoshi Yoshihara, Hiroyuki Takamatsu, et al.
American Journal of Hematology
|
November 20, 2024
Different impacts of granulocyte colony-stimulating factor administration on allogeneic hematopoietic cell transplant outcomes for adult acute myeloid leukemia according to graft type
Takaaki Konuma, Kazuaki Kameda, Kaoru Morita, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 2004
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
Yoshihiro Oka, Akihiro Tsuboi, Tetsuya Taguchi, et al.
Cancer Immunology, Immunotherapy : CII
|
May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients
Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, et al.
European Journal of Haematology
|
January 21, 2021
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis
Teruhito Takakuwa, Ryosuke Yamamura, Kensuke Ohta, et al.
Therapeutic Advances in Hematology
|
July 5, 2022
Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis
Yoshiyuki Onda, Junya Kanda, Hitomi Kaneko, et al.
Annals of Hematology
|
March 16, 2024
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study
Naokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa, et al.
British Journal of Haematology
|
April 25, 2023
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan
Tomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, et al.
Page
of 15